Fish Oil–Based Lipid Emulsions Prevent and Reverse Parenteral Nutrition–Associated Liver Disease: The Boston Experience
The DOI matches its Crossref record; 48 of the 48 references it cites were found in a registry or an index.
Abstract
Parenteral nutrition–associated liver disease (PNALD) is the most prevalent and most severe complication of long‐term parenteral nutrition. Its underlying pathophysiology, however, largely remains to be elucidated. The currently approved parenteral lipid emulsions in the United States contain safflower or soybean oils, both rich in ω‐6 polyunsaturated fatty acids (PUFAs). Mounting evidence indicates that the ω‐6 PUFAs originating from plant oils in these lipid emulsions may play a role in the onset of liver injury. Fish oil–based lipid emulsions, in contrast, are primarily composed of ω‐3 PUFAs, thus providing a promising alternative. The authors review the literature on the role of lipid emulsions in the onset of PNALD and discuss prevention and treatment strategies using a fish oil–based lipid emulsion. They conclude that a fish oil–based emulsion is hepatoprotective in a murine model of PNALD, and it appears to be safe and efficacious for the treatment of this type of liver disease in children. A prospective randomized trial that is currently under way at the authors' institution will objectively determine the place of fish oil monotherapy in the prevention of PNALD.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Long-Term Total Parenteral Nutrition with Growth, Development, and Positive Nitrogen Balance
Dudrick, S. J., Wilmore, D. W., Vars, H. M., & Rhoads, J. E. (2023) · 50 Landmark Papers every Pediatric Surgeon Should Know · doi:10.1201/b23252-44 · Cited by 1,083
Mixed messages: modulation of inflammation and immune responses by prostaglandins and thromboxanes
Tilley, S. L., Coffman, T. M., & Koller, B. H. (2001) · Journal of Clinical Investigation · doi:10.1172/jci200113416 · Cited by 726
Mixed messages: modulation of inflammation and immune responses by prostaglandins and thromboxanes
Tilley, S. L., Coffman, T. M., & Koller, B. H. (2001) · Journal of Clinical Investigation · doi:10.1172/jci13416 · Cited by 725 · cited 1×
“In addition, arachidonic acid is a key substrate for the eicosanoids prostaglandin E2, leukotrienes B4 and C4, thromboxane A2, and platelet aggregation factor, which are all recognized as potent proinflammatory mediators.(31) It has therefore been postulated that increased levels of ω-6 PUFAs can initiate or worsen in…”
BackgroundA case of human linolenic acid deficiency involving neurological abnormalities
Holman, R., Johnson, S., & Hatch, T. (1982) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/35.3.617 · Cited by 531
Howard, L., Ament, M., Richard Fleming, C., Shike, M., & Steiger, E. (1995) · Gastroenterology · doi:10.1016/0016-5085(95)90321-6 · Cited by 490 · cited 1×
“More than 30,000 patients in the United States are permanently dependent on PN for survival.(2) Long-term use of PN, however, is associated with many complications, including bloodstream infections, metabolic abnormalities, and organ dysfunction.”
BackgroundGura, K. M., Lee, S., Valim, C., Zhou, J., Kim, S., Modi, B. P., Arsenault, D. A., Strijbosch, R. A. M., Lopes, S., Duggan, C., et al. (2008) · Pediatrics · doi:10.1542/peds.2007-2248 · Cited by 455
Self-citationAndorsky, D. J., Lund, D. P., Lillehei, C. W., Jaksic, T., DiCanzio, J., Richardson, D. S., Collier, S. B., Lo, C., & Duggan, C. (2001) · The Journal of Pediatrics · doi:10.1067/mpd.2001.114481 · Cited by 448 · cited 2×
“Established risk factors for the development of PNALD are prematurity, low birth weight, duration of PN and number of septic episodes, and a diagnosis of gastroschisis or jejunal atresia.(5,8,10,11) The most effective treatment for PNALD is increasing enteral caloric intake while reducing PN,(12) but this process is o…”
BackgroundMethodImmune modulation by parenteral lipid emulsions
Wanten, G. J., & Calder, P. C. (2007) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/85.5.1171 · Cited by 416
Polyunsaturated fatty acids ameliorate hepatic steatosis in obese mice by SREBP-1 suppression
Sekiya, M., Yahagi, N., Matsuzaka, T., Najima, Y., Nakakuki, M., Nagai, R., Ishibashi, S., Osuga, J.-I., Yamada, N., & Shimano, H. (2003) · Hepatology · doi:10.1016/j.hep.2003.09.028 · Cited by 415 · cited 8×
“Furthermore, ω-3 PUFAs have been shown to accelerate the clearance of chylomicron triglycerides in humans, thus effectively reducing triacylglycerol concentrations in serum.51 Others have shown that an increase in clearance of triglycerides and a reduction in lipogenesis through suppression of sterol response element…”
BackgroundInfluentialNF-κB inhibition by ω-3 fatty acids modulates LPS-stimulated macrophage TNF-α transcription
Novak, T. E., Babcock, T. A., Jho, D. H., Helton, W. S., & Espat, N. J. (2003) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00077.2002 · Cited by 409
Peden, V. H., Witzleben, C. L., & Skelton, M. A. (1971) · The Journal of Pediatrics · doi:10.1016/s0022-3476(71)80289-5 · Cited by 397
Omega-3 fatty acid supplementation accelerates chylomicron triglyceride clearance
Park, Y., & Harris, W. S. (2003) · Journal of Lipid Research · doi:10.1194/jlr.m200282-jlr200 · Cited by 348
Gura, K. M., Duggan, C. P., Collier, S. B., Jennings, R. W., Folkman, J., Bistrian, B. R., & Puder, M. (2006) · Pediatrics · doi:10.1542/peds.2005-2662 · Cited by 344
Self-citationFirst year growth of preterm infants fed standard compared to marine oil n−3 supplemented formula
Carlson, S. E., Cooke, R. J., Werkman, S. H., & Tolley, E. A. (1992) · Lipids · doi:10.1007/bf02535870 · Cited by 337
Role of Lipid Emulsions in Cholestasis Associated with Long‐Term Parenteral Nutrition in Children
Colomb, V., Jobert‐Giraud, A., Lacaille, F., Goulet, O., Fournet, J., & Ricour, C. (2000) · Journal of Parenteral and Enteral Nutrition · doi:10.1177/0148607100024006345 · Cited by 309
Rallidis, L. S., Paschos, G., Liakos, G. K., Velissaridou, A. H., Anastasiadis, G., & Zampelas, A. (2003) · Atherosclerosis · doi:10.1016/s0021-9150(02)00427-6 · Cited by 288
Carter, B. A., Taylor, O. A., Prendergast, D. R., Zimmerman, T. L., Von Furstenberg, R., Moore, D. D., & Karpen, S. J. (2007) · Pediatric Research · doi:10.1203/pdr.0b013e3181256492 · Cited by 286
Randomization in clinical trials: Conclusions and recommendations
Lachin, J. M., Matts, J. P., & Wei, L. J. (1988) · Controlled Clinical Trials · doi:10.1016/0197-2456(88)90049-9 · Cited by 272 · cited 1×
“It eliminates bias and spurious causality, thus providing an outcome with the highest level of scientific evidence.(61,62) Although no trials have been completed to date, there are 2 randomized controlled trials under way investigating the use of the fish oil–based lipid emulsion Omegaven with PN.”
BackgroundClayton, P. T., Whitfield, P., & Iyer, K. (1998) · Nutrition · doi:10.1016/s0899-9007(97)00233-5 · Cited by 229
Chan, S., McCowen, K. C., Bistrian, B. R., Thibault, A., Keane-Ellison, M., Forse, R. A., Babineau, T., & Burke, P. (1999) · Surgery · doi:10.1067/msy.1999.98925 · Cited by 226
Alwayn, I. P. J., Gura, K., Nosé, V., Zausche, B., Javid, P., Garza, J., Verbesey, J., Voss, S., Ollero, M., Andersson, C., et al. (2005) · Pediatric Research · doi:10.1203/01.pdr.0000153672.43030.75 · Cited by 204 · cited 14×
“Furthermore, ω-3 PUFAs have been shown to accelerate the clearance of chylomicron triglycerides in humans, thus effectively reducing triacylglycerol concentrations in serum.51 Others have shown that an increase in clearance of triglycerides and a reduction in lipogenesis through suppression of sterol response element…”
BackgroundMethodInfluentialSelf-citationMayer, K., Meyer, S., Reinholz-Muhly, M., Maus, U., Merfels, M., Lohmeyer, J., Grimminger, F., & Seeger, W. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.171.9.4837 · Cited by 191
Nuclear factor kB is activated by arachidonic acid but not by eicosapentaenoic acid
Camandola, S., Leonarduzzi, G., Musso, T., Varesio, L., Carini, R., Scavazza, A., Chiarpotto, E., Baeuerle, P. A., & Poli, G. (1996) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1996.1857 · Cited by 188
Invited Review: Development of Fat Emulsions
WRETLIND, A. (1981) · Journal of Parenteral and Enteral Nutrition · doi:10.1177/0148607181005003230 · Cited by 172
Carter, B. A., & Shulman, R. J. (2007) · Nature Clinical Practice Gastroenterology & Hepatology · doi:10.1038/ncpgasthep0796 · Cited by 162
Effect of olive oil on immune function in middle-aged men
Yaqoob, P., Knapper, J., Webb, D., Williams, C., Newsholme, E., & Calder, P. (1998) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/67.1.129 · Cited by 160 · cited 1×
“The advantage of olive oil is thought to be the presence of ω-9 monounsaturated fatty acids (MUFAs), which preserve immune function.(35) Moreover, olive oil is rich in α-tocopherol which is a major antioxidant.”
BackgroundBabcock, T. A., Novak, T. E., Ong, E., Jho, D. H., Helton, W. S., & Espat, N. J. (2002) · Journal of Surgical Research · doi:10.1006/jsre.2002.6498 · Cited by 127
Intravenous lipid emulsions: removal mechanisms as compared to chylomicrons.
Hultin, M., Carneheim, C., Rosenqvist, K., & Olivecrona, T. (1996) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)39201-4 · Cited by 118
Gura, K. M., Parsons, S. K., Bechard, L. J., Henderson, T. O., Dorsey, M. J., Phipatanakul, W., Duggan, C., Puder, M., & Lenders, C. M. (2005) · Clinical Nutrition · doi:10.1016/j.clnu.2005.05.020 · Cited by 118
Self-citationChalmers, I. (2001) · International Journal of Epidemiology · doi:10.1093/ije/30.5.1156 · Cited by 114 · cited 1×
“It eliminates bias and spurious causality, thus providing an outcome with the highest level of scientific evidence.(61,62) Although no trials have been completed to date, there are 2 randomized controlled trials under way investigating the use of the fish oil–based lipid emulsion Omegaven with PN.”
BackgroundOlive oil in parenteral nutrition
Sala-Vila, A., Barbosa, V. M., & Calder, P. C. (2007) · Current Opinion in Clinical Nutrition and Metabolic Care · doi:10.1097/mco.0b013e32802bf787 · Cited by 110 · cited 1×
“This— together with the fact that oleic acid, the principal component of olive oil, is a MUFA and therefore resistant to lipid peroxidation—should make lipid emulsions containing olive oil particularly beneficial in patients at risk of oxidative stress.(36) Fish oil–based lipid emulsions are the most recent developmen…”
BackgroundCurrent Clinical Applications of Ω‐6 and Ω‐3 Fatty Acids
Lee, S., Gura, K. M., Kim, S., Arsenault, D. A., Bistrian, B. R., & Puder, M. (2006) · Nutrition in Clinical Practice · doi:10.1177/0115426506021004323 · Cited by 100
Self-citationParenteral Nutrition-Associated Cholestasis
Teitelbaum, D. H., & Tracy, T. F. (2001) · Seminars in Pediatric Surgery · doi:10.1053/spsu.2001.22386 · Cited by 92
Alwayn, I. P. J., Andersson, C., Zauscher, B., Gura, K., Nosé, V., & Puder, M. (2005) · Transplantation · doi:10.1097/01.tp.0000150023.86487.44 · Cited by 79 · cited 2×
“Thirty days of supplementation with enteral fish oil every other day improved hepatic steatosis by converting macrovesicular steatosis to microvesicular steatosis.(56) These findings indicate that the use of a fish oil–based lipid emulsion might help prevent as well as reverse PNALD.”
BackgroundMethodSelf-citationUse of fish oil in parenteral nutrition: rationale and reality
Calder, P. C. (2006) · Proceedings of the Nutrition Society · doi:10.1079/pns2006500 · Cited by 75 · cited 1×
“It has therefore been postulated that increased levels of ω-6 PUFAs can initiate or worsen inflammatory states.(32) Moreover, soybean-based lipid emulsions have been shown to have immunosuppres sive effects both in some in vitro(33) and clinical studies.”
BackgroundYeh, S. L., Chang, K.-Y., Huang, P., & Chen, W. J. (1997) · Nutrition · doi:10.1016/s0899-9007(97)90876-5 · Cited by 71
Dichtl, W., Ares, M. P. S., Niemann-Jönsson, A., Jovinge, S. V., Pachinger, O. M., Giachelli, C. M., Hamsten, A., Eriksson, P. O., & Nilsson, J. (2002) · Metabolism · doi:10.1053/meta.2002.29963 · Cited by 68
Omega‐3 fatty acids and liver disease†‡
Lee, S., Gura, K. M., & Puder, M. (2007) · Hepatology · doi:10.1002/hep.21645 · Cited by 65
Self-citationCarter, B., & Karpen, S. (2007) · Seminars in Liver Disease · doi:10.1055/s-2007-985070 · Cited by 63 · cited 1×
“Long-term use of PN, however, is associated with many complications, including bloodstream infections, metabolic abnormalities, and organ dysfunction.(3) First documented in 1971, the most prevalent and most severe complication continues to be hepatobiliary dysfunction, referred to as PN-associated liver disease (PNAL…”
BackgroundStrijbosch, R. A. M., Lee, S., Arsenault, D. A., Andersson, C., Gura, K. M., Bistrian, B. R., & Puder, M. (2008) · Metabolism · doi:10.1016/j.metabol.2008.01.008 · Cited by 56 · cited 4×
“As we previously reported, the ω-3 PUFAs α-linolenic acid, EPA, and DHA, which are present in fish oil, might play a role in reducing the amount of the ω-6 PUFA linoleic acid required to prevent EFAD.(57) Omegaven (Fresenius Kabi AG, Bad Homburg VDH, Germany) is the only commercially available lipid emulsion that cont…”
BackgroundInfluentialSelf-citationEffects of fish oil in parenteral nutrition
Chen, W., & Yeh, S. (2003) · Nutrition · doi:10.1016/s0899-9007(02)01009-2 · Cited by 51
Qi, K., Al-Haideri, M. T., Seo, T., Carpentier, Y. A., & Deckelbaum, R. J. (2003) · Journal of Parenteral and Enteral Nutrition · doi:10.1177/014860710302700158 · Cited by 47 · cited 1×
“In fact, it appears that they may be cleared as whole particles by tissues other than the liver.(24) Second, phytosterols found in soybean oils are thought to have a deleterious effect on liver function.”
BackgroundCalder, P. C., Sherrington, E. J., ASKANAZI, J., & Newsholme, E. A. (1994) · Clinical Nutrition · doi:10.1016/0261-5614(94)90062-0 · Cited by 42
Chen, W., Yeh, S., & Huang, P. (1996) · Clinical Nutrition · doi:10.1016/s0261-5614(96)80257-3 · Cited by 41
Park, H. J., Lee, Y. W., Hennig, B., & Toborek, M. J. (2001) · Nutrition and Cancer · doi:10.1080/01635581.2001.9680623 · Cited by 31
Alwayn, I. P. J., Javid, P. J., Gura, K. M., Nosé, V., Ollero, M., & Puder, M. (2004) · Hepatology · doi:10.1002/hep.20189 · Cited by 24
Self-citationChen, M.-F., Lee, Y., Hsu, H., Yeh, P.-C., Liau, C., & Huang, P. (1992) · International Journal of Cardiology · doi:10.1016/0167-5273(92)90299-i · Cited by 18
Putadechakum, S., Tanphaichitr, V., Leelahagul, P., Pakpeankitvatana, V., Surapisitchart, T., & Komindr, S. (2005) · PubMed · Cited by 15
Cited by
Injectable Lipid Emulsions—Advancements, Opportunities and Challenges
Hippalgaonkar, K., Majumdar, S., & Kansara, V. (2010) · AAPS PharmSciTech · doi:10.1208/s12249-010-9526-5 · Cited by 236
Metadata
- Authors
- de Meijer, V. E., Gura, K. M., Le, H. D., Meisel, J. A., & Puder, M.
- Venue
- Journal of Parenteral and Enteral Nutrition
- Publisher
- Wiley
- Published
- 2009-07
- Volume
- 33
- Issue
- 5
- Pages
- 541-547
- ISSN
- 0148-6071 (ISSN-L)
- 1941-2444
- OpenAlex
- W1965987624
- Cited by
- 166
- References
- 48
- FWCI
- 13.66
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.